tumblr stats

NIH-funded HIV clinical research sites to join pediatric tuberculosis vaccine study

vaccin

Several U.S. government-funded HIV/AIDS clinical research sites in Africa will join other collaborators in an ongoing clinical trial testing an investigational tuberculosis (TB) vaccine in infants at risk for TB infection. “We are pleased to be able to tap into our existing HIV/AIDS clinical research infrastructure to help test promising investigational vaccines against TB,” said [...]

SABIC at Pharmapack – New resins for healthcare

logo_sabic

At Pharmapack 2012, SABIC Launches New Resins to Reinforce Strong Portfolio of Thermoplastics for Healthcare Sittard, the Netherlands, 20120130 — Saudi Basic Industries Corporation (SABIC) will be at Pharmapack Europe (Paris, February 15-16), the annual European Healthcare event, with a wide range of polyolefins and engineering thermoplastics developed specifically for the global healthcare industry. The [...]

Enrollment in First MRgFUS Essential Tremor Feasibility Trial Completed

medicalheaderdevices

January issue of Neurosurgical Focus devoted to MRgFUS brain research InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS) therapy, announced today that it has completed enrollment in the world’s first feasibility study [http://www.clinicaltrials.gov/ct2/show/NCT01304758?term=ExAblate&rank=4 ] evaluating the use of MRgFUS for treatment of Essential [http://www.insightec.com/Essential_Tremor.html ] Tremor, using ExAblate(R) Neuro at University of [...]

8th European Healthcare Fraud and Corruption Network (EHFCN) Annual Conference

healthcare8_1

“Fighting fraud in healthcare and social security ? How to maximize results?”   Every year, approximately 56 billion ? are lost to fraud and error in healthcare alone across Europe; this is equivalent to the salaries of 2.5 million nurses or to the building of 3500 healthcare clinics throughout Europe?, Paul Vincke, President EHFCN Join [...]

Souvenaid: Milkshake to improve the memory with Alzheimer

brain

Souvenaid® is a once-a-day nutritional drink for memory. It contains key nutrients that interact to help build nerve connections in the brain. This patented combination of nutrients, called Fortasyn™ Connect, includes omega-3 fatty acids, choline, uridine monophosphate, and a mixture of antioxidants and B vitamins. Souvenaid® has been shown in a clinical study presented at [...]

Prev 1 2 3 4 5 Next

Malcolm Gladwell Health care innovations needs Cezanne-like innovators

malcolm Gladwell 1 Malcolm Gladwell Health care innovations needs Cezanne like innovatorsKeynote speaker and social commentator Malcolm Gladwell (author of Outliers, Blink and The Tipping Point) whose gift for articulating fresh ideas has influenced a generation of business leaders, was present at iSOFT‘s Ideaworks for Healthcare 09. Mr Gladwell opened the discussion by addressing whether we are at healthcare’s ‘Tipping Point’ and how to accelerate a new era of innovation in healthcare. He gave an interesting talk on two types of creativity, inspired by a book by David Galenson on Cezanne and Picasso.

Galenson writes that Picasso, a conceptual innovator, pretty much knew what he was going to create even before he created it, and came up with new ideas at a rapid pace early in his career. Cezanne, by contrast, was an experimental innovator, slowly rehashing and improving on a particular concept until he nailed it. Consequently, his greatest works–or at least the ones most valued by collectors–didn’t come until later in his life. (more…)

Written by

iSOFT Brings Together Leading Thinkers at ‘Ideaworks For Healthcare’

iSOFT Group Limited – one of the world’s biggest healthcare technology companies, brought together the world’s leading thinkers and creators of change to debate, challenge and discuss ideas on the future of healthcare innovation at its inaugural Ideaworks for Healthcare symposium in London this month. Ideaworks 09 (www.ideaworksforhealthcare.com) – which will be held at The [...]

October 31, 2009 1
Written by

SCYNEXIS Receives Milestone Payment in Oncology Collaboration with Merck & Co., Inc.

Drug discovery companySCYNEXIS, Inc. today announced that it has received a payment from Merck & Co., Inc. for achieving a preclinical milestone resulting from a collaboration to discover and develop novel oncology agents. “We are pleased to celebrate success in reaching another milestone with our valued partner, Merck,” said Yves Ribeill, Ph.D., President and Chief [...]

October 27, 2009 0
Written by

New Formulation for LUMIGAN® Eyedrops Receives Positive Opinion in Europe

Important step towards approval of enhanced glaucoma medication LUMIGAN® (bimatoprost ophthalmic solution) 0.01% in 27 countries within the European Union Amsterdam, The Netherlands, 23 October, 2009 – Allergan Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) has recommended granting a Marketing Authorisation for a new version of LUMIGAN® (bimatoprost ophthalmic [...]

October 26, 2009 0
Written by

FDA Approves New Vaccine for Prevention of Cervical Cancer

The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years. Genital HPV infections are the most common sexually-transmitted diseases in the United States, and HPV [...]

October 19, 2009 0
Written by

Ticagrelor Achieves Greater Efficacy In Trial

AstraZeneca PLc (AZN) Tuesday announced results from the phase III head to head trial, PLATO – a study of platelet inhibition and patient outcomes – which demonstrate that ticagrelor (BrilintaTM) has achieved greater efficacy in the primary endpoint, reduction of cardiovascular events over clopidogrel (9.8% vs 11.7% at 12 months; 16% RRR; 95% CI, 0.77 [...]

October 16, 2009 1
Page 5 of 7« First...«234567»

Advertentie

Advertisement